3. 结构
3.1 二维结构
3.2 三维结构
-1
-2
-3
25 26 0 0 0 0 0 0 0999 V2000
-0.0873 -1.1893 -1.3117 S 0 0 0 0 0 0 0 0 0 0 0 0
2.3415 -2.2310 0.3074 N 0 0 0 0 0 0 0 0 0 0 0 0
1.2335 -0.2305 -0.5765 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2749 -0.8299 0.1322 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.5091 -0.5135 -0.4693 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2009 1.1557 -0.7289 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2834 -0.0429 0.6885 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2094 1.9426 -0.1728 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.5981 -0.5961 0.9188 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5261 0.0951 -1.2022 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2506 1.3433 0.5359 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.7088 -0.0681 1.5770 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.6368 0.6231 -0.5440 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.7281 0.5415 0.8456 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4060 1.6489 -1.2832 H 0 0 0 0 0 0 0 0 0 0 0 0
4.1012 -0.4958 1.2434 H 0 0 0 0 0 0 0 0 0 0 0 0
2.1852 3.0217 -0.2929 H 0 0 0 0 0 0 0 0 0 0 0 0
-0.8191 -1.0724 1.5089 H 0 0 0 0 0 0 0 0 0 0 0 0
-2.4716 0.1684 -2.2855 H 0 0 0 0 0 0 0 0 0 0 0 0
4.0360 1.9560 0.9686 H 0 0 0 0 0 0 0 0 0 0 0 0
-2.7808 -0.1329 2.6587 H 0 0 0 0 0 0 0 0 0 0 0 0
-4.4305 1.0981 -1.1131 H 0 0 0 0 0 0 0 0 0 0 0 0
-4.5930 0.9524 1.3580 H 0 0 0 0 0 0 0 0 0 0 0 0
3.1049 -2.6434 0.8268 H 0 0 0 0 0 0 0 0 0 0 0 0
1.6178 -2.8195 -0.0836 H 0 0 0 0 0 0 0 0 0 0 0 0
1 3 1 0 0 0 0
1 5 1 0 0 0 0
2 4 1 0 0 0 0
2 24 1 0 0 0 0
2 25 1 0 0 0 0
3 4 1 0 0 0 0
3 6 2 0 0 0 0
4 7 2 0 0 0 0
5 9 2 0 0 0 0
5 10 1 0 0 0 0
6 8 1 0 0 0 0
6 15 1 0 0 0 0
7 11 1 0 0 0 0
7 16 1 0 0 0 0
8 11 2 0 0 0 0
8 17 1 0 0 0 0
9 12 1 0 0 0 0
9 18 1 0 0 0 0
10 13 2 0 0 0 0
10 19 1 0 0 0 0
11 20 1 0 0 0 0
12 14 2 0 0 0 0
12 21 1 0 0 0 0
13 14 1 0 0 0 0
13 22 1 0 0 0 0
14 23 1 0 0 0 0
4. 国际命名与标识
4.1 IUPAC Name
2-phenylsulfanylaniline
4.2 InChl
InChI=1S/C12H11NS/c13-11-8-4-5-9-12(11)14-10-6-2-1-3-7-10/h1-9H,13H2
4.3 InChlKey
DGBISJKLNVVJGD-UHFFFAOYSA-N
4.4 Canonical SMILES
C1=CC=C(C=C1)SC2=CC=CC=C2N
4.5 lsomeric SMILES
-
4.6 SDF文件
5. 波谱数据
5.1 13C核磁共振谱(13C NMR)
5.2 1H核磁共振谱(1H NMR)
5.3 质谱(MS)
5.4 红外光谱(IR)
5.5 紫外/可见光谱(UV/Vis)
6. 相关药材
7. 相关靶点
8. 相关疾病